Organon & (OGN) Earnings

In its last earnings report on February 13, 2025, Organon & reported earnings per share (EPS) of $0.90, compared to an estimated EPS of $0.92. The company reported revenue of $1.59B, compared to an estimated revenue of $1.59B.

Organon &'s current Price-to-Earnings (P/E) ratio is 4.44. The trailing twelve months (TTM) P/E ratio is 3.93. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.

For the fiscal year ending December 31, 2024, Organon & reported total revenue of $6.40B and net income of $864.00M. This represents a net profit margin of 0.1349367484.

Organon &'s earnings yield is 22.53%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.

Organon &'s return on equity (ROE) is 183.05%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.

Organon &'s gross profit margin is 58.02%. This indicates that for every dollar of revenue, the company retains $0.58 as gross profit after accounting for the cost of goods sold.